The company’s biobot, named Mona Lisa, generates 3D images from MRI and ultrasound scans to assist doctors in planning biopsies and surgery.

ZIG Ventures raised US$15 million from Korean biotech investors to support Curiox Biosystems’ global commercialization.

The company attended MEDICA, an international medical trade fair, from November 12–15, 2018.

ZIG Ventures invests in and collaborates with founders of healthcare biomedical technology companies.

ZIG Ventures is a venture investment and commercialization company that focuses on investing in healthcare innovations and develops these companies

Curiox Biosystems Co., Ltd. debuts on Korea’s KOSDAQ exchange with a 1.4 million-share IPO priced at 13,000 won per share. The offering marks the company’s first public listing, following its growth as a portfolio company. Curiox operates in the biotechnology sector, though specific details of its business were not disclosed in the update.

Aug 2023ZIG Ventures LimitedNews article

ZIG Ventures is accepting applications for its **ZIG Innovation Fellowship Program**, launched under the **Enterprise Singapore Innovation and Enterprise Fellowship (IFP) Programme**. The initiative partners with ZIG Ventures to support innovation projects, though specific details on eligibility or focus areas remain unstated.

Apr 2021ZIG Ventures LimitedNews article

Curiox Biosystems secures **$15 million** in funding from Korean biotech investors, backed by ZIG Ventures. The capital supports global expansion and commercialization of its medtech solutions. ZIG Ventures, a Singapore-based medtech investment firm, leads the investment as a cornerstone investor.

Oct 2019ZIG Ventures LimitedNews article